相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
R. Aguiar et al.
ARTHRITIS CARE & RESEARCH (2017)
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
Darren M. Roberts et al.
JOURNAL OF AUTOIMMUNITY (2015)
Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
Venkat Reddy et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
Helena Marco et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients
J. Westra et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
G. Cambridge et al.
JOURNAL OF AUTOIMMUNITY (2014)
Serum immunoglobulin G level in patients with lupus nephritis and the effect of treatment with corticosteroids and mycophenolate mofetil
D. Y. H. Yap et al.
LUPUS (2014)
Autoantibodies and SLE-the threshold for disease
Nancy J. Olsen et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes
M. Makatsori et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)
Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
Emilio Besada et al.
RHEUMATOLOGY (2014)
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie B. Condon et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
Eduardo F. Mysler et al.
ARTHRITIS AND RHEUMATISM (2013)
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
Robert A. Eisenberg et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)
M. Witt et al.
LUPUS (2013)
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Candido Diaz-Lagares et al.
AUTOIMMUNITY REVIEWS (2012)
Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase
Y. Mino et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics
Inmaculada De La Torre et al.
RHEUMATOLOGY (2012)
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
Sebastian Eickenberg et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
Y. K. Onno Teng et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Meryl Streep and the problems of clinical trials
David A. Isenberg
ARTHRITIS RESEARCH & THERAPY (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Pharmacokinetic Variability of Mycophenolic Acid and Its Glucuronide in Systemic Lupus Erythematosus Patients in Remission Maintenance Phase
Yasuaki Mino et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation
Tabitha Turner-Stokes et al.
RHEUMATOLOGY (2011)
Prevalência de deficiência de IgA em pacientes adultos com lúpus eritematoso sistêmico e estudo de sua associação com perfil clínico e de autoanticorpos
Ana Paula França Mantovani et al.
Revista Brasileira De Reumatologia (2011)
Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
Henrik E. Mei et al.
BLOOD (2010)
Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients
Beatriz Rodriguez-Bayona et al.
ARTHRITIS RESEARCH & THERAPY (2010)
The importance of natural IgM: scavenger, protector and regulator
Michael R. Ehrenstein et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Human Marginal Zone B Cells
Jean-Claude Weill et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
L. K. Hicks et al.
BONE MARROW TRANSPLANTATION (2009)
Dysregulation of germinal centres in autoimmune disease
Carola G. Vinuesa et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
D. Albert et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
G. Cambridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
D. A. Isenberg et al.
RHEUMATOLOGY (2007)
Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion
Menno C. van Zelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny
Jennifer H. Anolik et al.
CLINICAL IMMUNOLOGY (2007)
Common variable immunodeficiency in systemic lupus erythematosus
Monica Fernandez-Castro et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2007)
B cell depletion therapy in systemic lupus erythematosus: Longterm follow-up and predictors of response
Kristine P. Ng et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
MJ Leandro et al.
RHEUMATOLOGY (2005)
Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency
SH Lim et al.
BLOOD (2004)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus
T Takeuchi et al.
AUTOIMMUNITY (2001)
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
M Odendahl et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
